You have read all your free articles, to continue reading subscribe to read the rest of this content.
Recipharm has announced investment into a new facility in Uttarakhand, India which will see its fill finish capacity increase to 1 billion sterile units per year. The facility will be constructed on a greenfield site near Dehradun in Uttarakhand and is a joint project between Recipharm and the SoAlready a…
Novo Nordisk has announced plans to invest more than 17 billion Danish kroner in construction of three new manufacturing facilities as well as expansion of one existing facility at its production site in Kalundborg, Denmark. The investment will establish additional capacity across the entire gAlready a subscriber Login You have…
Airsupra (albuterol/budesonide), formerly known as PT027, has been approved in the US for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older. “With patients experiencing more than 10 million asthma Already a subscriber Login You have read…
Asarina Pharma, a drug development company focused on the development of a novel therapy for severe premenstrual symptoms, has completed a financing round raising EURO 7 million from new and existing investors for the continued clinical development of Sepranolone. Around 5% of women in fertile agAlready a subscriber Login You…
